Loading company…
Vitara Biomedical develops therapeutic medical devices for premature infants and neonatal care.
Vitara Biomedical is developing a therapeutic platform for premature infants, drawing on physiological processes to support neonatal care. The company was founded in 2019 and is based in Pennsylvania. In November 2024, it raised USD 50 million in Series B funding led by Sands Capital Ventures, with GV, First Spark Ventures, Khosla Ventures, and Flerie Invest participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in